Brokers' take
UG Healthcare | Buy (maintained) Aug 28 close: S$0.177 Target price: S$0.30 RHB Research Institute, Aug 28
Full-year revenue was up 17 per cent from the previous year. The new production facility - which achieved full commercialisation at end January - led to an additional annual capacity of 500 million pieces of gloves.
There was overall production efficiency and economies of scale, which contributed to the 47 per cent rise in FY2019 gross profit. UG's earnings for this period stood at S$0.54 million, down 59 per cent, mainly due to higher marketing, distribution, administrative, and finance expenses. Whilst FY2019 net profit disappointed, the gross profit rise reflects strength.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
TikTok tells advertisers: ‘We are not backing down’
EV automakers get reprieve in US tax credit rules
Nomura, Mizuho face losses on All Blue fund’s failed trades
Stablecoin Tether steps up monitoring in bid to combat illicit finance
HSBC asked by US$890 billion investor group to set energy goal
BHP’s biggest rivals sit on the sidelines of Anglo M&A drama